Notably, treatment usage trends from a Bladder Cancer Advocacy Network (BCAN) survey presented at GU ASCO 2025 revealed that only 1–5% of patients reported having seen a radiation oncologist and only ...

Annual Meeting held in Chicago, IL, was host to a State of the Science session on novel diagnostics and therapeutics in renal cell and urothelial carcinomas. Dr. Wulff-Burchfield discussed strategies ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

The vaccine is being used on dogs with three types of cancer — osteosarcoma, hemangiosarcoma, and urothelial carcinoma, a form of bladder cancer. Cancer is the top cause of death for dogs.

Bladder cancer is when a tumor grows in your bladder, a pouch-like organ that stores your urine. (Photo Credit: SEBASTIAN KAULITZKI/Science Source) The American Cancer Society’s estimates for ...

For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving ... Surveillance cystoscopy, imaging and urine cytology occurred after CRT every three to four months. During the ...

Urine samples were collected before cystoscopy and analyzed for PENK methylation, NMP22, and cytology. Pathological confirmation of bladder cancer was conducted by an independent pathologist ...

Not the dog waiting for him for weeks," one user wrote. Another said: "Dogs know. They always know." "The other pup knows," agreed another viewer. "They can smell the cancer." Research suggests ...

A urinary DNA methylation test displayed superior sensitivity for detecting high-grade or invasive bladder cancer, compared with the nuclear matrix protein 22 (NMP22) test or urine cytology test.

Secondary outcomes involved accuracy for overall bladder cancer detection and comparisons with NMP22 and urine cytology tests. Overall, 219 participants had bladder cancer, including 176 with high ...

Fetch’s predictive power to improve pet patient outcomes was recently demonstrated through FidoCure's newly secured patent, a novel targeted therapy and biomarker for canine bladder cancer.

Innovative diagnostic kit uses fluorescence-based detection to achieve 90% accuracy in identifying early-stage bladder cancer ... such as cystoscopy and urine cytology, are invasive, costly ...